DAM
EW icon

Deltec Asset Management’s Edwards Lifesciences EW Stock Holding History

Deltec Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,000
Closed -$480K – 268
2026
Q1 		$480K Hold
6,000
– – 0.09% 156
2025
Q4 		$512K Buy
+6,000
New +$492K 0.08% 136

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Deltec Asset Management's EW Position: Q2 2026 in Review

Deltec Asset Management sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 6,000 shares — an estimated $480K sold.

Deltec Asset Management first reported a position in EW in Q4 2025 and held it in 2 quarters. The position peaked at $512K in Q4 2025. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Deltec Asset Management reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Deltec Asset Management sold 6,000 Edwards Lifesciences shares in Q2 2026, an estimated $480K.
  • Deltec Asset Management first reported a position in Edwards Lifesciences in Q4 2025 and held it in 2 quarters.
  • Deltec Asset Management's Edwards Lifesciences position peaked at $512K in Q4 2025.
  • 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Deltec Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.